Source: Annual Congress 2006 - MP5 – How to use new immunosuppressive drugs in lung transplantation



Rating:

Share or cite this content

Citations should be made in the following way:
A. Boehler (Zurich, Switzerland), G. Verleden (Leuven, Belgium). How to use new immunosuppressive drugs in lung transplantation. Annual Congress 2006 - MP5 – How to use new immunosuppressive drugs in lung transplantation

Member's Comments

No comment yet.

Related content which might interest you: Immunosuppressive therapy after human lung transplantation Source: Eur Respir J 2004; 23: 159-171 Year: 2004 Airway cellular response to two different immunosuppressive regimens in lung transplant recipients Source: Eur Respir J 2004; 24: Suppl. 48, 466s Year: 2004 Immunosuppressive therapy after human lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=105 Year: 2003 Impact of antifibrotic drugs in lung transplantation Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes Year: 2019 New antifibrotic drugs: will interstitial diseases patients still need lung transplantation? Source: Virtual Congress 2020 – Lung transplantation in the era of new drugs Year: 2020 The influence of different immunosuppressive regimen on non-mnestic cognitive functions in patients after lung transplantation Source: International Congress 2014 – Maximise lung transplant outcomes: pre- and post-operative issues Year: 2014 Medical complications of lung transplantation Source: Eur Respir J 2004; 23: 334-342 Year: 2004 Lung transplantation for pulmonary hypertension: the impact of new drug therapies Source: Annual Congress 2004 - Lung transplantation: new insights in advanced lung disease and new drug developments - do they impact on selection criteria? Year: 2004 Lung disease induced by novel chemotherapeutic agents and biomolecules Source: Annual Congress 2006 - Drug-induced lung injury – new aspects Year: 2006 Improving the innate immune response in respiratory infections: the use of repurposed drugs Source: Virtual Congress 2020 – Antibiotic resistance: the way forward Year: 2020 A new method to estimate the long-term effect of immunosuppressants and vasodilator therapies on lung function outcomes in systemic sclerosis patients Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Use of immune cell function assay in immune surveillance of lung transplant recipients: Correlations with clinical outcome and other immune assays Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 From ineffective tumor immune response to immunomodulation in lung cancer Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies? Year: 2017 The humoral immune response to influenza vaccination in lung transplant patients Source: Eur Respir J 2001; 18: 971-976 Year: 2001 Infectious complications after lung transplantation Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=193 Year: 2003 Effects of two immunosuppressive triple therapies on inflammatory cells in lung Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009 Early sirolimus immunosuppression is safe in lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Immunotherapy improves inflammatory response and lymphocyte apoptosis as a new therapeutic target in sepsis rat Source: Annual Congress 2009 - Severe sepsis and multiple organ failure Year: 2009